Showing results (1191-1200 of 1,350) with videos related to

Sort By:
Pageof 135
Drug Development Research|August 12, 2023
Mesenchymal stem cell-derived rapid drug screening system for Alzheimer's disease for the identification of novel drugsNaisarg Gamit, Manasi Patil, Soumya B Sundrappa, et al.
Drug Development Research|August 14, 2023
A liposomal radionanoformulation for targeted drug delivery and real time monitoring by radionuclide imaging for HER2 overexpressing cancersShishu Kant Suman, Archana Mukherjee, Rohit Kumar Sharma
Drug Development Research|October 20, 2023
AS602801 treatment suppresses breast cancer metastasis to the brain by interfering with gap-junction communication by regulating Cx43 expressionZhigang Yang, Liguo Yang, Jun Zhang, et al.
Drug Development Research|October 25, 2023
Design, synthesis, and in-silico study of novel triarylethylene analogs with dual anti-estrogenic and serotonergic activityTammy Mostafa, Miriam Albeir, Jannette Wober, et al.
Drug Development Research|September 28, 2023
Fluoxetine enhances the antitumor effect of olfactory ensheathing cell-thymidine kinase/ganciclovir gene therapy in human glioblastoma multiforme cells through upregulation of Connexin43 levelsSaereh Hosseindoost, Ahmad R Dehpour, Samaneh Dehghan, et al.
Drug Development Research|September 26, 2023
Pyridazine derivatives as selective COX-2 inhibitors: A review on recent updatesSara Y Ewieda, Eman M Ahmed, Rasha A Hassan, et al.
Drug Development Research|September 21, 2023
Discovery of novel pyrido[3,2-d]pyrimidine derivatives as selective and potent PI3Kδ inhibitorsHuanrong Bai, Jiajia Sun, Hao Lei, et al.
Drug Development Research|January 5, 2019
Graph theoretical analysis, in silico modeling, prediction of toxicity, metabolism and synthesis of novel 2-(methyl/phenyl)-3-(4-(5-substituted-1,3,4-oxadiazol-2-yl) phenyl) quinazolin-4(3H)-ones as NMDA receptor inhibitorGovindaraj Saravanan, Theivendren Panneerselvam, Selvaraj Kunjiappan, et al.
Drug Development Research|December 5, 2018
Mechanism of penehyclidine hydrochloride on a dysmenorrhea rat modelHongtao Xiao, Tingting Shi, Lizhu Han, et al.
Drug Development Research|December 5, 2018
Evaluation of selected commercial pharmacotherapeutic drugs as potential pancreatic lipase inhibitors and antiproliferative compoundsNoor Mamdooh, Violet Kasabri, Yusuf Al-Hiari, et al.
Pageof 135